231 related articles for article (PubMed ID: 12750546)
1. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.
Fisher M;
Stroke; 2003 Jun; 34(6):1539-46. PubMed ID: 12750546
[TBL] [Abstract][Full Text] [Related]
2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable.
Fisher M; Albers GW; Donnan GA; Furlan AJ; Grotta JC; Kidwell CS; Sacco RL; Wechsler LR;
Stroke; 2005 Aug; 36(8):1808-13. PubMed ID: 16020764
[TBL] [Abstract][Full Text] [Related]
4. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
Savitz SI; Fisher M
Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
[TBL] [Abstract][Full Text] [Related]
5. Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.
Jovin TG; Albers GW; Liebeskind DS;
Stroke; 2016 Oct; 47(10):2656-65. PubMed ID: 27586682
[TBL] [Abstract][Full Text] [Related]
6. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.
Albers GW; Goldstein LB; Hess DC; Wechsler LR; Furie KL; Gorelick PB; Hurn P; Liebeskind DS; Nogueira RG; Saver JL;
Stroke; 2011 Sep; 42(9):2645-50. PubMed ID: 21852620
[TBL] [Abstract][Full Text] [Related]
7. The future of basic science research and stroke: hubris and translational stroke research.
Lyden P
Int J Stroke; 2011 Oct; 6(5):412-3. PubMed ID: 21951405
[No Abstract] [Full Text] [Related]
8. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents.
Cramer SC; Koroshetz WJ; Finklestein SP
Stroke; 2007 Apr; 38(4):1393-5. PubMed ID: 17332455
[TBL] [Abstract][Full Text] [Related]
9. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview.
Grupke S; Hall J; Dobbs M; Bix GJ; Fraser JF
Clin Neurol Neurosurg; 2015 Feb; 129():1-9. PubMed ID: 25497127
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on neuroprotective stroke therapy.
Schäbitz WR; Fisher M
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1271-6. PubMed ID: 17073800
[TBL] [Abstract][Full Text] [Related]
11. Future directions of acute ischaemic stroke therapy.
Fisher M; Saver JL
Lancet Neurol; 2015 Jul; 14(7):758-67. PubMed ID: 26067128
[TBL] [Abstract][Full Text] [Related]
12. Developing therapy for acute ischemic stroke.
Fisher M
Therapie; 2002; 57(6):564-8. PubMed ID: 12666264
[TBL] [Abstract][Full Text] [Related]
13. A Stroke Recovery Trial Development Framework: Consensus-Based Core Recommendations from the Second Stroke Recovery and Rehabilitation Roundtable.
Bernhardt J; Hayward KS; Dancause N; Lannin NA; Ward NS; Nudo RJ; Farrin A; Churilov L; Boyd LA; Jones TA; Carmichael ST; Corbett D; Cramer SC
Neurorehabil Neural Repair; 2019 Nov; 33(11):959-969. PubMed ID: 31674274
[TBL] [Abstract][Full Text] [Related]
14. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.
Gladstone DJ; Black SE; Hakim AM;
Stroke; 2002 Aug; 33(8):2123-36. PubMed ID: 12154275
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trials.
Donnan GA; Davis SM; Kaste M;
Stroke; 2003 Apr; 34(4):1041-5. PubMed ID: 12649514
[TBL] [Abstract][Full Text] [Related]
16. Update of the stroke therapy academic industry roundtable preclinical recommendations.
Fisher M; Feuerstein G; Howells DW; Hurn PD; Kent TA; Savitz SI; Lo EH;
Stroke; 2009 Jun; 40(6):2244-50. PubMed ID: 19246690
[TBL] [Abstract][Full Text] [Related]
17. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
Köhrmann M; Schellinger PD; Schwab S
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
[TBL] [Abstract][Full Text] [Related]
18. Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era.
Savitz SI; Baron JC; Fisher M;
Stroke; 2019 Mar; 50(4):1026–1031. PubMed ID: 31166683
[No Abstract] [Full Text] [Related]
19. Recommendations for clinical trial evaluation of acute stroke therapies.
Stroke Therapy Academic Industry Roundtable II (STAIR-II)
Stroke; 2001 Jul; 32(7):1598-606. PubMed ID: 11441207
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct.
Hjort N; Butcher K; Davis SM; Kidwell CS; Koroshetz WJ; Röther J; Schellinger PD; Warach S; Østergaard L;
Stroke; 2005 Feb; 36(2):388-97. PubMed ID: 15618445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
